Labeling cell surface glycosylphosphatidylinositol-anchored proteins through metabolic engineering using an azide-modified phosphatidylinositol.

Labeling cell surface glycosylphosphatidylinositol-anchored proteins through metabolic engineering using an azide-modified phosphatidylinositol.
复制标题

DOI:
10.1016/j.bbrc.2023.01.029
复制
发表时间:
2023-02-19
影响因子:
3.1
通讯作者:
Guo, Zhongwu
Guo, Zhongwu
中科院分区:
生物学4区
文献类型:
--
作者:
Kundu, Sayan;Jaiswal, Mohit;Craig, Kendall C.;Guo, Jiatong;Guo, Zhongwu

文献摘要

参考文献

相似文献

糖基磷脂酰肌醇(GPI)锚定是真核细胞质膜上最常见的蛋白附着机制之一。gpi锚定蛋白(GPI-APs)在许多生物过程中起着至关重要的作用,但很难研究。本研究利用叠氮修饰的磷脂酰肌醇(PI)作为细胞表面gpi - ap的生物合成前体,建立了一种有效的、选择性的代谢工程和标记方法。结果表明,该叠氮化物- pi衍生物被HeLa细胞吸收并结合到gpi的生物合成途径中,在活细胞表面呈现叠氮化物标记的GPI-APs。叠氮基团作为分子手柄,通过生物相容性点击反应安装其他标签,实现荧光成像、蛋白下拉等多种生物学研究,有助于探索gpi - ap的功能,发现新的gpi - ap。
Glycosylphosphatidylinositol (GPI) anchorage is one of the most common mechanisms to attach proteins to the plasma membrane of eukaryotic cells. GPI-anchored proteins (GPI-APs) play a critical role in many biological processes but are difficult to study. Here, a new method was developed for the effective and selective metabolic engineering and labeling of cell surface GPI-APs with an azide-modified phosphatidylinositol (PI) as the biosynthetic precursor of GPIs. It was demonstrated that this azido-PI derivative was taken up by HeLa cells and incorporated into the biosynthetic pathway of GPIs to present azide-labeled GPI-APs on the live cell surface. The azido group was used as a molecular handle to install other labels through a biocompatible click reaction to enable various biological studies, e.g., fluorescent imaging and protein pull-down, which can help explore the functions of GPI-APs and discover new GPI-APs.
DOI: 10.1126/science.3340856
发表时间: 1988-02-12
期刊: SCIENCE
影响因子: 56.9
作者:
FERGUSON, MAJ;HOMANS, SW;RADEMACHER, TW
通讯作者: RADEMACHER, TW
DOI: 10.1007/s10719-008-9116-x
发表时间: 2009-11
影响因子: 3
作者:
Mehlert, Angela;Ferguson, Michael A. J.
通讯作者: Ferguson, Michael A. J.
DOI: 10.1021/acschembio.1c00465
发表时间: 2021-11-19
影响因子: 4
作者:
Guerrero PA;Murakami Y;Malik A;Seeberger PH;Kinoshita T;Varón Silva D
通讯作者: Varón Silva D
GPI-AP:揭开新的恶性介质和潜在的免疫疗法靶标。
DOI: 10.3389/fonc.2020.537311
发表时间: 2020
影响因子: 4.7
作者:
Hussein NH;Amin NS;El Tayebi HM
通讯作者: El Tayebi HM
DOI: 10.1074/mcp.m300079-mcp200
发表时间: 2003-12-01
影响因子: 7
作者:
Elortza, F;Nühse, TS;Jensen, ON
通讯作者: Jensen, ON